Weight Loss News and Research

Latest Weight Loss News and Research

Weight loss related to fewer hot flashes in menopausal women: study

Hot flashes are an uncomfortable and distressing part of menopause that many women go through. Hot flashes also known as hot flushes are usually sudden sweatiness and redness in the face that can remain for four or five years into menopause. Now researchers have shown that losing weight may help reduce these symptoms.

13 Jul 2010

Obesity crisis in the spotlight as FDA reviews weight loss drugs

The Washington Post explores the obesity epidemic by reporting from Manchester, Ky., which has an obesity rate as high as 52 percent in a nation where the obesity rate is 24 percent. "The residents of this town of 2,100 — 95 miles southeast of Lexington and deep in the Appalachian foothills — indeed appear to celebrate the joys of community closeness.

13 Jul 2010

New research evaluates effectiveness of popular slimming supplements

New research evaluating the effectiveness of a broad selection of popular slimming supplements sold in pharmacies and health food shops has found no evidence that any of them facilitate weight loss beyond the placebo effect.

12 Jul 2010

Experimental anti-obesity and diabetes drug avoids risk of psychiatric side effects: Study

A second-generation experimental anti-obesity and diabetes drug has shown promise in reducing body weight in rodents just as effectively as the predecessor rimonabant while avoiding the risk of psychiatric side effects that led to the withdrawal of rimonabant from the market and stopped further development of other brain-penetrating drugs of its type.

12 Jul 2010

Survival rates for people diagnosed with once-deadly cancer increase: Cancer Research UK

People diagnosed with breast, bowel and ovarian cancers and non-Hodgkin's lymphoma are today twice as likely to survive for at least 10 years as those diagnosed in the early 1970s according to new figures1 released by Cancer Research UK.

12 Jul 2010

Study shows association between obesity and GERD in children

Extremely obese children have a 40 percent higher risk of gastroesophageal reflux disease and children who are moderately obese have a 30 percent higher risk of GERD compared to normal weight children, according to a Kaiser Permanente study published online in the International Journal of Pediatric Obesity.

9 Jul 2010

Community-based wellness program helps reduce obesity, chronic inflammatory diseases: Study

Tackling weight loss, risk of chronic disease and overall well-being as part of a like-minded social community can dramatically influence an individual's success rate, according to a new study published in the July 2010 issue of the Center for Disease Control's Preventing Chronic Disease journal.

9 Jul 2010

Que She herbal weight loss supplement contains harmful ingredients, FDA warns

The U.S. Food and Drug Administration today warned that Que She, marketed as an herbal weight loss supplement, contains active pharmaceutical ingredients not listed on the product label that could harm consumers, especially those with cardiovascular conditions.

9 Jul 2010

Smart for Life Cookie Diet selected to receive 2010-2011 Shining Star Award

The trailblazing company whose Smart for Life weight management products featuring the Smart for Life Cookie Diet component was recently selected to receive the Unicorn Children's Foundation 2010-2011 Shining Star Award. This award recognizes an individual or organization that has brought significant awareness to the issues associated with developmental, communication, and learning disorders.

8 Jul 2010

Dietary protein intake may reduce bone density in overweight, postmenopausal women: Research

Overweight and moderately obese postmenopausal women using diets based on higher protein intake also need to be aware of potential bone loss, according to new research from Purdue University.

8 Jul 2010

Physical activity has little role to play in obesity epidemic among children: EarlyBird Diabetes Study

A new report from the EarlyBird Diabetes Study suggests that physical activity has little if any role to play in the obesity epidemic among children. Obesity is the key factor behind diabetes, heart disease and some cancers.

8 Jul 2010

Researchers show unexpected, physiological effects of water

Name a drink that can make you more alert for late-night studying, prevent you from fainting after giving blood, and even promote a teensy bit of weight loss. Chances are you didn't say water. But that's the right answer.

7 Jul 2010

Medifast announces grand opening of Texas Distribution Center in Coppell

Medifast, Inc. today announced the grand opening of a 50,000 square foot Texas Distribution Center located in Coppell, Tx., just outside of Dallas. The facility will support West Coast shipping for Medifast Direct; Take Shape For Life, Medifast's personal coaching division; and Medifast Weight Control Centers.

7 Jul 2010

POMC neurons suppress appetite, induce weight loss: Research

A protein found in cells throughout the body must be present in a specific set of neurons in the brain to prevent weight gain after chronic feeding on high-calorie meals, new findings from UT Southwestern Medical Center researchers suggest.

7 Jul 2010

Plant extract effective against ulcerative colitis in mice

A South Dakota State University scientist's research shows an extract made from a food plant in the Brassica family was effective in alleviating signs of ulcerative colitis, an inflammatory bowel condition, in mice.

2 Jul 2010

Study results of triple combination therapy in patients with diabetes and hypertension presented at ADA 2010

Preliminary results of a pre-specified subgroup study analysis of patients with diabetes and hypertension demonstrated that the investigational triple combination therapy of olmesartan medoxomil / amlodipine / hydrochlorothiazide (40/10/25 mg) resulted in a statistically significant greater Least Squares mean reduction in blood pressure from baseline at week 12 (37.9/22.0 mm Hg versus 26.4-28.0/14.7-17.6 mm Hg, P less than or equal to 0.0013) as compared to corresponding dual combination therapy [olmesartan medoxomil (40 mg) / amlodipine (10 mg); olmesartan medoxomil (40 mg) / hydrochlorothiazide (25 mg); or amlodipine (10 mg) and hydrochlorothiazide (25 mg)].

1 Jul 2010

Afinitor more than doubles progression-free survival in advanced pancreatic NET: Study

Novartis Pharmaceuticals Corporation announced today that results of a Phase III study show Afinitor® (everolimus) tablets plus best supportive care (BSC) more than doubled progression-free survival, or time without tumor growth, versus placebo plus BSC in patients with advanced pancreatic neuroendocrine tumors (NET). The study, RADIANT-3, was presented at the 12th World Congress on Gastrointestinal Cancer and is part of the largest clinical trial program in patients with advanced NET.

1 Jul 2010

Eisai to commercialize lorcaserin for obesity and weight management in U.S.

Arena Pharmaceuticals, Inc. today announced that Eisai Inc. will market lorcaserin for obesity and weight management in the United States following U.S. Food and Drug Administration (FDA) approval under the terms of a marketing and supply agreement between Arena Pharmaceuticals GmbH, a wholly owned subsidiary of Arena Pharmaceuticals, Inc., and Eisai. Lorcaserin, which Arena discovered and has developed for weight management, is intended for obese patients as well as overweight patients who have at least one weight-related co-morbid condition.

1 Jul 2010

Eisai signs agreement with Arena Pharmaceuticals GmbH to commercialize lorcaserin

Eisai Inc., the U.S. pharmaceutical operation of Tokyo-based Eisai Co., Ltd., announced today that it has entered into an agreement with Arena Pharmaceuticals GmbH, a wholly owned subsidiary of Arena Pharmaceuticals, Inc., for exclusive U.S. rights to commercialize lorcaserin, a drug candidate for potential use in the treatment of obesity, including weight loss, for patients who are obese (Body Mass Index or BMI ≥ 30) or overweight (BMI ≥ 27) with at least one weight-related co-morbid condition.

1 Jul 2010

Eisai reports preliminary results from Dacogen for Injection Phase III study in AML

Eisai Inc. announced today preliminary results from a randomized Phase III clinical trial of Dacogen® (decitabine) for Injection versus either a low-dose chemotherapy agent or supportive care in elderly patients with acute myeloid leukemia (AML), a life-threatening cancer of the blood that generally occurs in older adults.

1 Jul 2010

Weight Loss News and Research

Latest Weight Loss News and Research

Weight loss related to fewer hot flashes in menopausal women: study

Obesity crisis in the spotlight as FDA reviews weight loss drugs

New research evaluates effectiveness of popular slimming supplements

Experimental anti-obesity and diabetes drug avoids risk of psychiatric side effects: Study

Survival rates for people diagnosed with once-deadly cancer increase: Cancer Research UK

Study shows association between obesity and GERD in children

Community-based wellness program helps reduce obesity, chronic inflammatory diseases: Study

Que She herbal weight loss supplement contains harmful ingredients, FDA warns

Smart for Life Cookie Diet selected to receive 2010-2011 Shining Star Award

Dietary protein intake may reduce bone density in overweight, postmenopausal women: Research

Physical activity has little role to play in obesity epidemic among children: EarlyBird Diabetes Study

Researchers show unexpected, physiological effects of water

Medifast announces grand opening of Texas Distribution Center in Coppell

POMC neurons suppress appetite, induce weight loss: Research

Plant extract effective against ulcerative colitis in mice

Study results of triple combination therapy in patients with diabetes and hypertension presented at ADA 2010

Afinitor more than doubles progression-free survival in advanced pancreatic NET: Study

Eisai to commercialize lorcaserin for obesity and weight management in U.S.

Eisai signs agreement with Arena Pharmaceuticals GmbH to commercialize lorcaserin

Eisai reports preliminary results from Dacogen for Injection Phase III study in AML

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Weight Loss News and Research

Latest Weight Loss News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in